Clinical Trials Logo

Filter by:
NCT ID: NCT05010278 Not yet recruiting - Shoulder Luxation Clinical Trials

Evaluation of Factors Associated With Return to Sports Activity Six Months After Anterior Shoulder Stabilisation With Latarjet.

ERASME
Start date: September 2021
Phase:
Study type: Observational

On a population of sports patients who had undergone a Latarjet operation for post-traumatic anterior shoulder instability, reviewed in consultation 6 months after the operation as part of an ordinary follow-up and divided into two groups according to their current sports practice. Group 1: "SUCCESS": return to the same level in the same sport. Group 2: "FAILURE": return to the same sport with a reduced level or change of sport or significant reduction or cessation of sporting activity.

NCT ID: NCT05009927 Recruiting - C-KIT Mutation Clinical Trials

Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)

Start date: January 3, 2022
Phase: Phase 2
Study type: Interventional

This is a 2 arms study concerning patients under imatinib treatment for at least 10 years of treatment with locally advanced/metastatic GIST. In the first arm, patients will discontinue Imatinib treatment. This arm will allow to determine if the re-introduction of Imatinib at relapse is still an efficient treatment for the control of disease. In the second arm, patients will continue Imatinib treatment, allowing to determine if the continuation of this treatment is efficient for disease control, by the rate of non-progression disease.

NCT ID: NCT05009797 Recruiting - Atrial Fibrillation Clinical Trials

PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation

PROSPECT-AF
Start date: February 16, 2023
Phase:
Study type: Observational

Atrial fibrillation ablation is the most common intervention performed worldwide. Up to 20 to 45% of patients show recurrence of AF within 12 month after catheter ablation, however its determinant are incompletely understood. The aim of the PROSPECT-AF study is to assess the predictors of AF recurrence within the 3 years following ablation using clinical variables and innovative biomarkers in a prospective cohort of 750 patients undergoing atrial fibrillation catheter ablation. The secondary aims are to assess the incidence of major adverse cardiovascular outcomes (MACE) and the incidence of major bleeding within the 3 years Wolfing catheter ablation.

NCT ID: NCT05009628 Completed - Clinical trials for Postoperative Oxygen Therapy

Is Routine Postoperative Oxygen Therapy Still Necessary in 2020?

FreeO2
Start date: July 5, 2021
Phase: N/A
Study type: Interventional

The purpose of this study by automated control of oxygen supply in the immediate postoperative period is to show the possibility of immediate weaning in the postoperative period in case of remifentanil use and complete reversion of curarization.

NCT ID: NCT05009537 Recruiting - MDS Clinical Trials

Optical Genome Mapping in Hematological Malignancies

CARTOGEN
Start date: September 2021
Phase:
Study type: Observational

Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer

NCT ID: NCT05009407 Recruiting - Angiogenesis Clinical Trials

CD160 Expression in Corneal Vessels

Start date: April 21, 2021
Phase:
Study type: Observational

Despite improvements in corneal transplantation, anti-angiogenic and anti-lymphangiogenic factors remain to be be identified. CD160 is an anti-angiogenic target: its expression seems to be restricted to some immune cells and to activated endothelial cells. We hypothesized that CD160 is expressed in blood and lymphatic human corneal neovessels and is involved in corneal graft rejection pathogenesis

NCT ID: NCT05009342 Terminated - Ankle Injuries Clinical Trials

Evaluation of Functional Outcomes at 2 Months According to Therapeutic Management, in Trauma With Low-grade Osteo-ligamentous Ankle Injury in Children

CHEVIPED
Start date: September 9, 2021
Phase: N/A
Study type: Interventional

Lack of current consensus on the therapeutic management of low-grade osteo-ligament injuries in ankle trauma in children. Several types of immobilization are evaluated in the literature, with different conclusions. Some teams recommend a functional treatment similar to the adult (with or without strict immobilization), others remain on standard rigid immobilizations. The goal of the study is to simplify and homogenize the therapeutic management of low-grade osteo-ligament injuries in ankle trauma in children.

NCT ID: NCT05008926 Recruiting - Brain Injuries Clinical Trials

The NIPA Study Naloxegol Administration to Prevent Opioids Induced Gastrointestinal Motility Disturbance in Brain Injured PAtients

NIPA
Start date: March 15, 2022
Phase: Phase 3
Study type: Interventional

Impaired gastrointestinal transit (IGT) especially constipation, is common among patients under mechanical ventilation, occurring in up to 80 % of the patients during the first week, and has been associated with worse outcome in intensive care unit (ICU). Although IGT in critically ill patients is multifactorial and some components are due to complex disease, there is increasing evidence that exogenous opioids contribute to bowel dysmotility. Sedatives and especially opioids are largely used in the brain injured population to control intracranial pression, reduce metabolic rate, manage or prevent seizures, and improve mechanical ventilator synchrony. Therefore, brain injured patients are particularly at risk to develop IGT. The occurrence of IGT is associated with adverse outcomes in intensive care unit. Both gastric reflux and impaired peristaltic contractions are associated with ventilator-acquired pneumonia. The actual challenge is to prevent motility disorders before it occurs. A preventive strategy could in turn reduce the occurrence of complications related to impaired gastrointestinal transit such as ventilator-acquired pneumonia, bacteremia etc. It could also reduce the complications of feed intolerance and thus reduce morbidity and mortality in ICU. Naloxegol is a polyethylene glycol derivative of naloxol, which is a derivative of naloxone and a peripherally acting µ-opioid receptor antagonist. Contrary to naloxone, naloxegol has a very low penetration into the central nervous system, therefore it could be a relevant option for ileus prevention without the risk of impaired sedation. The aim of our study is to assess the efficacy of the administration of naloxegol on the onset of early constipation and early ventilator-acquired pneumonia in brain injured patients receiving opioids for analgosedation.

NCT ID: NCT05008731 Not yet recruiting - Clinical trials for Hamstring Contractures

Effect of Botulinum Toxin on Hamstring Contracture and the Occurrence of Cyclops Syndrome After Anterior Cruciate Ligament Reconstruction

SCALA
Start date: October 2021
Phase: Phase 3
Study type: Interventional

Monocentric, prospective, randomised, double-blind study of two parallel groups of 66 patients with post-reconstruction ACL hamstring contracture treated with an ultrasound-guided injection at two points on the body of the hamstring - Group 1: botulinum toxin: 100 units (0.5ml) in 1 injection - Group 2: placebo: 0.5 ml in 1 injection

NCT ID: NCT05008497 Not yet recruiting - Cancer Clinical Trials

Cancer and Literacy in Health

CaLiS
Start date: September 2021
Phase:
Study type: Observational

Validation in French of a psychometric tool for measuring health literacy in the field of cancer